Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Non-interventional/Observational Patient Cohort Study on the Efficacy of Intranasal Fentanyl Spray for the Treatment of Breakthrough Pain in Cancer Patients.

NCT00994760 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT00994760
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00994760 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Non-interventional/Observational Patient Cohort Study on the Efficacy of Intranasal Fentanyl Spray for the Treatment of Breakthrough Pain in Cancer Patients.
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
September 30, 2009
Completion date
November 30, 2010
Enrollment
131 (actual)
Sites
168

Conditions

As the registry lists them; a condition with its own page is linked.

breakthrough pain, cancer